Q1 2025 Management View CEO Phil Horlock emphasized the company's near-record adjusted EBITDA of $46 million and a 15% margin in Q1 2025, highlighting strong demand for school buses and a healthy ...
Thomas J. Klima, the Chief Commercial and Operating Officer of bluebird bio, Inc. (NASDAQ:BLUE), recently sold shares of the company’s common stock. According to a recent SEC filing, Klima disposed of ...
Some results have been hidden because they may be inaccessible to you